HomeHKMPF • OTCMKTS
add
Hikma Pharmaceuticals Plc
Previous close
$22.91
Day range
$22.36 - $22.83
Year range
$22.36 - $28.92
Market cap
3.61B GBP
Avg Volume
612.00
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 829.00M | 5.67% |
Operating expense | 175.50M | -0.85% |
Net income | 119.00M | 5.31% |
Net profit margin | 14.35 | -0.35% |
Earnings per share | — | — |
EBITDA | 238.00M | -4.61% |
Effective tax rate | 18.64% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 236.00M | -9.23% |
Total assets | 5.55B | 14.59% |
Total liabilities | 3.00B | 17.90% |
Total equity | 2.55B | — |
Shares outstanding | 221.45M | — |
Price to book | 2.00 | — |
Return on assets | 8.42% | — |
Return on capital | 11.38% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 119.00M | 5.31% |
Cash from operations | 80.50M | -18.69% |
Cash from investing | -107.50M | -102.83% |
Cash from financing | 49.00M | 288.46% |
Net change in cash | 24.00M | 54.84% |
Free cash flow | 79.88M | -31.36% |
About
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Founded
1978
Website
Employees
9,500
